"En el año 2019, TN Group adquirió la institución con el fin de brindar más y mejores servicios de salud a sus beneficiarios. Desde aquel entonces, iniciamos un proceso de inversión y crecimiento con el objetivo de mejorar la calidad de atención en todos los aspectos. Por este motivo, y para acompañar el proceso, fue necesario cambiar el concepto de Clínica a Sanatorio, ya que los avances que logramos juntos nos posicionan en esta nueva categoría. Como toda evolución, viene acompañado de grandes cambios, Clínica del Prado ahora es SANATORIO CÓRDOBA."

During the past decade, Clinica Privada del Prado conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Privada del Prado" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Bayer" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "NYU Langone Health" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Privada del Prado" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Privada del Prado" are "Cardiovascular Diseases" (2 trials), "Heart Diseases" (2 trials), "Coronary Artery Disease" (1 trials), "Coronary Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Clinica Privada del Prado" in a lesser frequency.

Most popular intervention types in "Clinica Privada del Prado" are "Drug" (6 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (1 trials), "Finerenone (BAY94-8862)" (1 trials), "K-877" (1 trials) and "Lifestyle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Privada del Prado" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Privada del Prado". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinica Privada del Prado, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Privada del Prado, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".